drugset / Trial / NCT05287867

Trial for Treating Painful Degenerative Disc Disease

NCT05287867

Recruiting 42 enrolled Regenexx, LLC
RandomizedCrossoverSingle-blindTreatment

Summary

To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.

Timeline

Start
2022-05-06
Primary completion
2026-12-31
Completion
2026-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Lysate Unknown 2 ml Other
Subject Platelet Poor Plasma Unknown 2.5 ml Intramuscular
Subject Platelet Rich Plasma Other / unclassified 1 ml Other